The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic imaging, and increasing prevalence of chronic diseases. Valued at USD 30.74 billion in 2024, the market grew to USD 32.95 billion in 2025 and is projected to reach USD 60.82 billion by 2034, expanding at a CAGR of 7.17% during the forecast period.
Market value: USD 30.74 billion in 2024
Projected to reach USD 60.82 billion by 2034
CAGR: 7.17% (2025–2034)
North America held the largest market share in 2024 (approx. 41%)
Asia Pacific expected to be the fastest-growing region
By product type, catheters accounted for about 28% revenue share in 2024
About: Medtronic is a global leader in medical technology, offering innovative therapies for various medical specialties.
Products: Advanced stents, catheters, and embolization devices for interventional radiology.
Market Cap: Approx. USD 110 billion.
About: Boston Scientific develops devices that improve patient outcomes across multiple therapeutic areas.
Products: Drug-eluting stents, guidewires, and embolization systems.
Market Cap: Approx. USD 90 billion.
About: Cordis, a part of Johnson & Johnson, focuses on cardiovascular and endovascular medical devices.
Products: Balloon catheters, vascular closure devices, and guidewires.
Market Cap: Johnson & Johnson – Approx. USD 360 billion.
About: Stryker is a leading medical technology company specializing in orthopedics, surgical equipment, and neurovascular devices.
Products: Neurovascular thrombectomy devices, access systems, and clot retrieval devices.
Market Cap: Approx. USD 130 billion.
About: Siemens Healthineers delivers cutting-edge imaging and diagnostic solutions worldwide.
Products: Angiography systems, CT scanners, and hybrid OR imaging solutions.
Market Cap: Approx. USD 65 billion.
About: GE HealthCare is a leader in diagnostic imaging, ultrasound, and interventional solutions.
Products: Angio suites, fluoroscopy systems, and hybrid imaging systems.
Market Cap: Approx. USD 33 billion.
About: Philips Healthcare focuses on integrated diagnostic and therapeutic imaging solutions.
Products: Image-guided therapy systems, angiography, and interventional ultrasound.
Market Cap: Approx. USD 27 billion.
About: Cook Medical specializes in minimally invasive medical device solutions.
Products: Catheters, embolization coils, and drainage products.
Market Cap: Private company (estimated revenue over USD 2 billion annually).
About: Terumo is a Japanese multinational known for cardiovascular and medical device innovations.
Products: Embolization systems, microcatheters, and guidewires.
Market Cap: Approx. USD 20 billion.
About: BD is a global medical technology company serving healthcare institutions worldwide.
Products: Biopsy needles, vascular access devices, and drainage catheters.
Market Cap: Approx. USD 70 billion.
About: Abbott focuses on diagnostics, medical devices, nutritionals, and branded generics.
Products: Vascular closure devices, imaging catheters, and balloon catheters.
Market Cap: Approx. USD 180 billion.
About: Merit Medical specializes in disposable devices for diagnostic and interventional procedures.
Products: Guidewires, hemostasis valves, and drainage catheters.
Market Cap: Approx. USD 5 billion.
About: AngioDynamics provides devices for minimally invasive medical treatments.
Products: Angiographic catheters, thrombectomy systems, and ablation devices.
Market Cap: Approx. USD 0.4 billion.
About: Penumbra develops medical devices for neuro and vascular interventions.
Products: Aspiration systems, thrombectomy devices, and embolization coils.
Market Cap: Approx. USD 8 billion.
About: Canon Medical offers imaging solutions for diagnostic and interventional radiology.
Products: CT, MRI, and angiography systems.
Market Cap: Parent company Canon Inc. – Approx. USD 24 billion.
About: Ziehm Imaging is known for mobile C-arm technology for interventional procedures.
Products: Mobile C-arms, hybrid OR imaging systems.
Market Cap: Private company.
About: Shimadzu delivers imaging and analytical instrumentation solutions.
Products: Angiography systems, X-ray imaging, and fluoroscopy.
Market Cap: Approx. USD 4 billion.
About: BTG International specializes in products for oncology and vascular conditions.
Products: Embolization therapies, catheter systems, and drug-device combinations.
Market Cap: Acquired by Boston Scientific in 2019.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
1. What is interventional radiology?
Interventional radiology is a medical specialty that uses minimally invasive imaging-guided procedures to diagnose and treat various conditions.
2. Which region dominates the interventional radiology market?
North America currently leads the market, contributing about 41% of the global revenue in 2024.
3. What is driving the growth of the interventional radiology market?
The market is driven by rising demand for minimally invasive procedures, advancements in imaging technology, and an increasing burden of chronic diseases.
4. Which product segment holds the largest share?
Catheters lead the market, accounting for about 28% of revenue in 2024.
5. What is the market outlook for the next decade?
The market is expected to grow at a CAGR of 7.17%, reaching around USD 60.82 billion by 2034.
Source : https://www.towardshealthcare.com/insights/interventional-radiology-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5928
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More
The Direct-To-Consumer Genetic Testing Market is witnessing a global transformation, driven by the growing consumer demand for personalized healthcare insights.… Read More